Safety and Efficacy of Evolocumab in Ischemic Stroke
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the effect of evolocumab in combination with
statin therapy (atorvastatin) in acute ischemic stroke (AIS).
Phase:
Phase 4
Details
Lead Sponsor:
Second Affiliated Hospital of Guangxi Medical University